---
$id: https://graph.org.ai/products/commodity/51171715
$type: Product
source: UNSPSC
code: "51171715"
title: "Bismuth subgallate"
class: "51171700"
classTitle: "Antidiarrheals"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bismuth subgallate

**UNSPSC Code**: 51171715
**Class**: [Antidiarrheals](Antidiarrheals.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a topical anti-infective agent with the molecular formula C7H4O5.Bi.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YIW503MI7V, chemically known as 1,3,2-benzodioxabismole-5-carboxylic acid, 2,7-dihydroxy- but generally known as bismuth subgallate, which bears US NIH Compound Identifier 16682999. European Medicines Agency schedules Bismuth subgallate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13091MIG. As of Q4 2014, BISMUTH SUBGALLATE remains the US FDA Preferred Term for this commodity. Bismuth subgallate bears US NLM identifiers UMLS ID C0053790 and NCI Concept Code C77029. SMILES: [Bi]1(Oc2c(O1)cc(cc2O)C(=O)O)[OH2].

